About Us
Tectonic Platforms is an advanced analytics company leveraging machine learning and augmented AI to identify hidden patterns in high-risk, high-impact domains. Founded at the intersection of healthcare and technology, we initially focused on analyzing clinical trial performance through novel reliability frameworks.
As our platform evolved over the years, so did its potential.
Today, we apply our proprietary technology to financial markets—specifically to investment strategies tied to clinical and biotech catalysts. Through Swiss-based financial structures, including Actively Managed Certificates (AMCs), we translate predictive insight into targeted investment opportunities.
Our technology is purpose-built to extract actionable intelligence from fragmented, underappreciated data—enabling investors to make more confident decisions in uncertain markets.
Who we are
Tectonic Investor Intelligence was founded by clinical trial professionals with over 60 years of combined experience. Our proprietary AI analytical models are informed by extensive historical case studies spanning venture-backed, small-cap, and large pharmaceutical companies globally. Our founders recognized a recurring pattern of promising assets failing clinical trials not due to inherent limitations of the therapy itself, but rather as a result of suboptimal clinical trial management. This observation led to the development of our unique clinical trial success factors, which have demonstrated a strong correlation with trial and program outcomes.